Biomarker start-up raises $7M; Miraculins markets non-invasive cholesterol test;

> The Woburn, MA-based start-up Avantra has raised $7 million in Series A cash. The company is advancing assets it acquired from Decision Biomarkers, which filed for bankruptcy late last year. Story

> Canada's Miraculins is marketing a non-invasive test that can measure cholesterol levels through the skin. Report

> Chronix Biomedical says it is accelerating its biomarker development capabilities with the installation of Germany's first state-of-the-art high-throughput DNA mass sequencer at the University of Göttingen, Chronix's long-time collaborator. Chronix release

> Advanced Cell Diagnostics has launched the RNAscope FFPE Assay Kit, a line of RUO (Research-Use-Only) products designed to detect RNA biomarkers in routine Formalin-Fixed, Paraffin-Embedded tissue specimens with single molecule sensitivity. ACD release

And Finally... Elevated levels of the enzyme alpha-amylase in saliva offer a clear biological indicator of stress, which may flag problems for any woman trying to conceive a child. Feature